Failed Neuroprotection of Combined Inhibition of L-Type and ASIC1a Calcium Channels with Nimodipine and Amiloride

Jonas Ort,Benedikt Kremer,Linda Grüßer,Romy Blaumeiser-Debarry,Hans Clusmann,Mark Coburn,Anke Höllig,Ute Lindauer

DOI: https://doi.org/10.3390/ijms21238921

IF: 5.6

2020-11-24

International Journal of Molecular Sciences

Abstract:Effective pharmacological neuroprotection is one of the most desired aims in modern medicine. We postulated that a combination of two clinically used drugs—nimodipine (L-Type voltage-gated calcium channel blocker) and amiloride (acid-sensing ion channel inhibitor)—might act synergistically in an experimental model of ischaemia, targeting the intracellular rise in calcium as a pathway in neuronal cell death. We used organotypic hippocampal slices of mice pups and a well-established regimen of oxygen-glucose deprivation (OGD) to assess a possible neuroprotective effect. Neither nimodipine (at 10 or 20 μM) alone or in combination with amiloride (at 100 μM) showed any amelioration. Dissolved at 2.0 Vol.% dimethyl-sulfoxide (DMSO), the combination of both components even increased cell damage (p = 0.0001), an effect not observed with amiloride alone. We conclude that neither amiloride nor nimodipine do offer neuroprotection in an in vitro ischaemia model. On a technical note, the use of DMSO should be carefully evaluated in neuroprotective experiments, since it possibly alters cell damage.

biochemistry & molecular biology,chemistry, multidisciplinary

What problem does this paper attempt to address?

### The Problem Addressed by the Paper

This paper attempts to address whether the combined use of nimodipine (an L-type voltage-gated calcium channel blocker) and amiloride (an acid-sensing ion channel inhibitor) can produce a synergistic neuroprotective effect in ischemic brain injury. Specifically, the researchers hypothesize that the combined use of these two drugs can effectively prevent the increase in intracellular calcium concentration, thereby reducing neuronal cell death.

### Research Background

Ischemic brain injury is a common cerebrovascular disease, and its pathophysiological processes include excitotoxicity, oxidative stress, cortical spreading depolarization, inflammatory response, and apoptosis. Among these, the increase in intracellular calcium concentration is considered one of the key factors leading to neuronal death. Nimodipine and amiloride prevent calcium ions from entering the cell through different pathways, so researchers hope that their combined use can produce better neuroprotective effects.

### Experimental Methods

The researchers used a mouse hippocampal tissue slice model and conducted oxygen-glucose deprivation (OGD) experiments to simulate ischemic brain injury. In the experiments, nimodipine and amiloride were used either alone or in combination and dissolved in different concentrations of dimethyl sulfoxide (DMSO). Cell death was assessed using propidium iodide (PI) staining.

### Main Findings

1. **Effect of Single Drugs**: When nimodipine (10 or 20 µM) was used alone, it did not show significant neuroprotective effects in either 0.1% or 1.0% DMSO.
2. **Effect of Combined Drugs**: When nimodipine (10 or 20 µM) was combined with amiloride (100 µM) in 1.0% DMSO, it also did not show significant neuroprotective effects. However, when these two drugs were combined and dissolved in 2.0% DMSO, it significantly increased cell damage.
3. **Effect of DMSO**: 2.0% DMSO itself caused significant cell damage in the control group but did not further increase damage in the OGD group. 1.0% DMSO showed a slight protective trend in the OGD group, but it was not significant.

### Conclusion

The study results indicate that neither nimodipine nor amiloride, whether used alone or in combination, provided significant neuroprotective effects in the in vitro ischemic model. Additionally, high concentrations of DMSO (2.0%) have obvious toxic effects on cells, which may interfere with the effects of the drugs. Therefore, the researchers suggest cautious use of DMSO in future neuroprotection experiments and consideration of its potential side effects.